Origin Therapeutics Holdings (XCNQ:ORIG) Gross Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Origin Therapeutics Holdings's Gross Profit for the three months ended in Jun. 2023 was C$0.00 Mil. Origin Therapeutics Holdings's Revenue for the three months ended in Jun. 2023 was C$0.00 Mil. Therefore, Origin Therapeutics Holdings's Gross Margin % for the quarter that ended in Jun. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for Origin Therapeutics Holdings's Gross Margin % or its related term are showing as below:

XCNQ:ORIG's Gross Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 47
* Ranked among companies with meaningful Gross Margin % only.

Origin Therapeutics Holdings had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Origin Therapeutics Holdings was 0.00% per year.

Origin Therapeutics Holdings Gross Margin % Historical Data

The historical data trend for Origin Therapeutics Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Gross Margin % Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Gross Margin %

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Gross Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Gross Margin % falls into.

Origin Therapeutics Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Origin Therapeutics Holdings's Gross Margin for the fiscal year that ended in Sep. 2022 is calculated as

Gross Margin % (A: Sep. 2022 )	=	Gross Profit (A: Sep. 2022 )	/	Revenue (A: Sep. 2022 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

Origin Therapeutics Holdings's Gross Margin for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )	=	Gross Profit (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Origin Therapeutics Holdings (XCNQ:ORIG) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Origin Therapeutics Holdings had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Origin Therapeutics Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.